(Reuters) - "Such action may include the nomination of new directors to Ventana's Board and/or proposals to amend Ventana's bylaws," Roche said in a statement.
Ventana's board earlier unanimously rebuffed the offer, saying the hostile bid undervalues the diagnostics company and its prospects in the fast-growing cancer-testing market.
Read more at Reuters.com Hot Stocks News
Ventana's board earlier unanimously rebuffed the offer, saying the hostile bid undervalues the diagnostics company and its prospects in the fast-growing cancer-testing market.
Read more at Reuters.com Hot Stocks News
No comments:
Post a Comment